Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Isatuximab by Sanofi for Primary Systemic Amyloidosis: Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Primary Systemic Amyloidosis. According to GlobalData, Phase...
Isatuximab by Sanofi for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Peripheral T-Cell Lymphomas (PTCL). According to GlobalData,...
Isatuximab by Sanofi for Mantle Cell Lymphoma: Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Mantle Cell Lymphoma. According to GlobalData, Phase...
Isatuximab by Sanofi for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Diffuse Large B-Cell Lymphoma. According to GlobalData,...
Isatuximab by Sanofi for Natural Killer Cell Lymphomas: Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Natural Killer Cell Lymphomas. According to GlobalData,...
Isatuximab by Sanofi for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)....
Isatuximab by Sanofi for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)....
Isatuximab by Sanofi for Natural Killer Cell Lymphomas: Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Phase II for Natural Killer Cell Lymphomas. According to GlobalData,...
Isatuximab by Sanofi for Multiple Myeloma (Kahler Disease): Likelihood of Approval
Isatuximab is under clinical development by Sanofi and currently in Pre-Registration for Multiple Myeloma (Kahler Disease). According to GlobalData, Pre-Registration...